BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1655234)

  • 1. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients.
    Cohn-Cedermark G; Rutqvist LE; Rosendahl I; Silfverswärd C
    Cancer; 1991 Nov; 68(9):2017-22. PubMed ID: 1655234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and Ki-67 expression as prognostic factors in cystosarcoma phyllodes.
    Erhan Y; Zekioglu O; Ersoy O; Tugan D; Aydede H; Sakarya A; Kapkaç M; Ozdemir N; Ozbal O; Erhan Y
    Breast J; 2002; 8(1):38-44. PubMed ID: 11856160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary treatment of cystosarcoma phyllodes of the breast.
    Chaney AW; Pollack A; McNeese MD; Zagars GK; Pisters PW; Pollock RE; Hunt KK
    Cancer; 2000 Oct; 89(7):1502-11. PubMed ID: 11013364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
    Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
    Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phyllodes tumor (cystosarcoma phyllodes) of the breast. A clinicopathologic study of 45 cases.
    Inoshita S
    Acta Pathol Jpn; 1988 Jan; 38(1):21-33. PubMed ID: 2834912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
    Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
    J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.
    Spanheimer PM; Murray MP; Zabor EC; Stempel M; Morrow M; Van Zee KJ; Barrio AV
    Ann Surg Oncol; 2019 Jul; 26(7):2136-2143. PubMed ID: 30783853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phyllodes tumor of the breast.
    Belkacémi Y; Bousquet G; Marsiglia H; Ray-Coquard I; Magné N; Malard Y; Lacroix M; Gutierrez C; Senkus E; Christie D; Drumea K; Lagneau E; Kadish SP; Scandolaro L; Azria D; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):492-500. PubMed ID: 17931796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant cystosarcoma phyllodes.
    Staren ED; Lynch G; Boyle C; Witt TR; Bines SD
    Am Surg; 1994 Aug; 60(8):583-5. PubMed ID: 8030812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors.
    Asoglu O; Ugurlu MM; Blanchard K; Grant CS; Reynolds C; Cha SS; Donohue JH
    Ann Surg Oncol; 2004 Nov; 11(11):1011-7. PubMed ID: 15525831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystosarcoma phyllodes in adolescent girls and young women: a study of 45 patients.
    Rajan PB; Cranor ML; Rosen PP
    Am J Surg Pathol; 1998 Jan; 22(1):64-9. PubMed ID: 9422317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
    Jia C; Mei F; Zheng J; You JF; Liu JY
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content and proliferative activity of cystosarcoma phyllodes of the breast. Potential prognostic significance.
    el-Naggar AK; Ro JY; McLemore D; Garnsy L
    Am J Clin Pathol; 1990 Apr; 93(4):480-5. PubMed ID: 2157332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases.
    Pietruszka M; Barnes L
    Cancer; 1978 May; 41(5):1974-83. PubMed ID: 206344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options and recurrence potential for cystosarcoma phyllodes.
    Palmer ML; De Risi DC; Pelikan A; Patel J; Nemoto T; Rosner D; Dao TL
    Surg Gynecol Obstet; 1990 Mar; 170(3):193-6. PubMed ID: 2154867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast.
    Barrio AV; Clark BD; Goldberg JI; Hoque LW; Bernik SF; Flynn LW; Susnik B; Giri D; Polo K; Patil S; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2961-70. PubMed ID: 17562113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
    Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes.
    Hawkins RE; Schofield JB; Fisher C; Wiltshaw E; McKinna JA
    Cancer; 1992 Jan; 69(1):141-7. PubMed ID: 1309302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystosarcoma phyllodes. A clinicopathologic study of 26 cases.
    Ward RM; Evans HL
    Cancer; 1986 Nov; 58(10):2282-9. PubMed ID: 3019505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.